The core capabilities of Aquaporin A/S are 1) Fermentation and purification of membrane proteins at kilogram scale 2) Design of polymersomes leading to highly stable and active membrane protein formulation 3) Development and production of water filtration membranes based on this biomimetic technique Traditionally, membrane proteins are produced in research labs or assayed directly in living cells. Aquaporin's production process constitutes the largest scale membrane proteins have ever been produced at. Further, we have proven capabilities to formulate active and stable membrane proteins in large scale and at a cost orders of magnitude lower than conventional methods. This allows a new paradigme in applications of membrane proteins, simply due to availability and cost.
Primary Application Area: Biotech, Pharma
Technology Development Status: Proven Manufacturability
Technology Readiness Level: TRL 6
Vetted Programs/Awards: Awarded with Inventor of the Year 2014 by the European Patent Office
Organization Type: Commercial Startup (C+)
Showcase Booth #: 13M
GOVT/EXTERNAL FUNDING SOURCES
External Funding to Date: Aquaporin has raised capital in several rounds since its founding in 2005.